Vincent M Brandenburg
Overview
Explore the profile of Vincent M Brandenburg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
2231
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Spaderna H, Brandenburg V, Lauterbach M, Partetzke T, Schwab S, Voss F, et al.
PLoS One
. 2024 Sep;
19(9):e0309952.
PMID: 39236063
Aims: Fear of physical activity (PA) is discussed as a barrier to regular exercise in patients with heart failure (HF), but HF-specific theoretical concepts are lacking. This study examined associations...
2.
Rapp N, Brandenburg V, Kaesler N, Bakker S, Stohr R, Schuh A, et al.
Nutrients
. 2021 Oct;
13(10).
PMID: 34684491
Vitamin K dependent proteins (VKDP), such as hepatic coagulation factors and vascular matrix Gla protein (MGP), play key roles in maintaining physiological functions. Vitamin K deficiency results in inactive VKDP...
3.
Perello J, Ferrer M, Perez M, Kaesler N, Brandenburg V, Behets G, et al.
Br J Pharmacol
. 2020 Jun;
177(19):4400-4415.
PMID: 32557649
Background And Purpose: No therapy is approved for vascular calcification or calcific uraemic arteriolopathy (calciphylaxis), which increases mortality and morbidity in patients undergoing dialysis. Deposition of hydroxyapatite (HAP) crystals in...
4.
Stohr R, Brandenburg V, Heine G, Maeder M, Leibundgut G, Schuh A, et al.
Eur J Heart Fail
. 2020 Feb;
22(4):701-709.
PMID: 32020782
Aim: Fibroblast growth factor 23 (FGF23) is an intensively studied biomarker at the crossroads of cardiovascular disease, heart failure (HF) and chronic kidney disease. Independent associations between increasing FGF23 levels...
5.
Brandenburg V, Schuh A, Kramann R
Adv Chronic Kidney Dis
. 2019 Dec;
26(6):464-471.
PMID: 31831124
Accelerated and premature cardiovascular calcification is a hallmark of patients with chronic kidney disease (CKD) or end-stage renal disease (ESRD). The presence and the amount of cardiovascular calcification are among...
6.
Brandenburg V, Sinha S, Torregrosa J, Garg R, Miller S, Canals A, et al.
J Nephrol
. 2019 Aug;
32(5):811-821.
PMID: 31401795
Background: Calciphylaxis in end-stage renal disease is characterized by painful necrotic skin ulcers and high mortality. There are no approved therapies. SNF472, an intravenous formulation of myo-inositol hexaphosphate, inhibits the...
7.
Nigwekar S, Thadhani R, Brandenburg V
N Engl J Med
. 2018 Jul;
379(4):399-400.
PMID: 30044942
No abstract available.
8.
Brandenburg V, Verhulst A, Babler A, DHaese P, Evenepoel P, Kaesler N
Nephrol Dial Transplant
. 2018 May;
34(3):408-414.
PMID: 29846712
Canonical Wnt signalling activity is a major player in physiological and adaptive bone metabolism. Wnt signalling is regulated by soluble inhibitors, with sclerostin being the most widely studied. Sclerostin's main...
9.
Nigwekar S, Thadhani R, Brandenburg V
N Engl J Med
. 2018 May;
378(18):1704-1714.
PMID: 29719190
No abstract available.
10.
Hoffmann J, Hellwig S, Brandenburg V, Spaderna H
Int J Behav Med
. 2017 Dec;
25(3):294-303.
PMID: 29230643
Purpose: Fear of physical activity (FoPA) has been suggested as a psychological barrier to exercise-based cardiac rehabilitation and everyday physical activity (PA) in patients with heart failure (HF). We evaluated...